HuagongsheHuagongshe Chemistry Print Report · For research reference only
[5-(Trifluoromethyl)thiophen-2-yl]methyl 4-methylbenzenesulfonate → 4-[4-(4-Fluorophenyl)-4-hydroxypiperidin-1-yl]-1-{[5-(trifluoromethyl)thiophen-2-yl]methyl}-1,3,5-triazin-2(1H)-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | [5-(Trifluoromethyl)thiophen-2-yl]methyl 4-methylbenzenesulfonate | HCID 117839221 | — |
| Reactant | HCID 178517890 | HCID 178517890 | — |
| Product | 4-[4-(4-Fluorophenyl)-4-hydroxypiperidin-1-yl]-1-{[5-(trifluoromethyl)thiophen-2-yl]methyl}-1,3,5-triazin-2(1H)-one | HCID 117839420 | 13% |
Reaction Steps
4-[4-(4-Fluorophenyl)-4-hydroxypiperidin-1-yl]-1,3,5-triazin-2(1H)-one (100 mg, 0.34 mmol) synthesized in Reference Synthesis Example 14 and [5-(trifluoromethyl)thiophen-2-yl]methyl 4-methylbenzenesulfonate (558 mg, 0.67 mmol) synthesized in Reference Synthesis Example 51 were used to obtain the title compound (20 mg, yield 13%) by synthesis in a similar manner to Reference Synthesis Example 8.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09403798B2 |
| Source dataset | uspto-grants-2016_08 |
| ORD ID | ord-1219a4ebf91b45e38900501d0afda030 |
| Source note | uspto-grants-2016_08 |